bluebird bio Inc (BLUE)
0.321
-0.04
(-11.47%)
USD |
NASDAQ |
Nov 15, 16:00
0.321
0.00 (0.00%)
After-Hours: 16:31
bluebird bio Free Cash Flow (Quarterly): -66.31M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -66.31M |
March 31, 2024 | -76.45M |
December 31, 2023 | -19.05M |
September 30, 2023 | -92.39M |
June 30, 2023 | -60.21M |
March 31, 2023 | -72.46M |
December 31, 2022 | -24.65M |
September 30, 2022 | -78.29M |
June 30, 2022 | -100.34M |
March 31, 2022 | -126.15M |
December 31, 2021 | -141.78M |
September 30, 2021 | -156.68M |
June 30, 2021 | -149.23M |
March 31, 2021 | -210.95M |
December 31, 2020 | -163.08M |
September 30, 2020 | -154.40M |
June 30, 2020 | 34.94M |
March 31, 2020 | -216.80M |
December 31, 2019 | -172.37M |
September 30, 2019 | -138.32M |
June 30, 2019 | -156.48M |
March 31, 2019 | -173.48M |
December 31, 2018 | -142.62M |
September 30, 2018 | -96.63M |
June 30, 2018 | -113.64M |
Date | Value |
---|---|
March 31, 2018 | -116.27M |
December 31, 2017 | -114.21M |
September 30, 2017 | -60.24M |
June 30, 2017 | -67.02M |
March 31, 2017 | -101.33M |
December 31, 2016 | -82.13M |
September 30, 2016 | -48.39M |
June 30, 2016 | -46.50M |
March 31, 2016 | -40.66M |
December 31, 2015 | -36.52M |
September 30, 2015 | -30.12M |
June 30, 2015 | -13.53M |
March 31, 2015 | -25.32M |
December 31, 2014 | -18.07M |
September 30, 2014 | -22.54M |
June 30, 2014 | -13.34M |
March 31, 2014 | -14.45M |
December 31, 2013 | -10.74M |
September 30, 2013 | -10.98M |
June 30, 2013 | -8.706M |
March 31, 2013 | 65.21M |
December 31, 2012 | -6.992M |
September 30, 2012 | -4.263M |
June 30, 2012 | -4.165M |
March 31, 2012 | -6.491M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-216.80M
Minimum
Mar 2020
34.94M
Maximum
Jun 2020
-107.72M
Average
-100.34M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
Perspective Therapeutics Inc | -9.917M |
Protalix BioTherapeutics Inc | -3.782M |
Predictive Oncology Inc | -3.224M |
Spectral AI Inc | -1.626M |
AIM ImmunoTech Inc | -3.237M |